Gastroesophageal Reflux  >>  dexlansoprazole  >>  Phase 2
Welcome,         Profile    Billing    Logout  

3 Trials

Remove FilterRemove Filter

 
Trial + Data / EventsStatusPhNRegionInterventionsSponsorConditionsPrimary complStudy compl
dexlansoprazole / Generic mfg.
NCT01642602 / 2012-001680-72: Safety and Efficacy of Dexlansoprazole Delayed-Release Capsules in Treating Symptomatic Non-Erosive Gastroesophageal Reflux Disease in Adolescents

Completed
2
104
US, Europe, RoW
Dexlansoprazole, Dexilant, TAK-390MR
Takeda
Gastroesophageal Reflux Disease
01/14
01/14
NCT01642615 / 2012-001681-15: Safety and Efficacy of Dexlansoprazole Delayed-Release Capsules for Healing of Erosive Esophagitis and Maintenance of Healed Erosive Esophagitis and Relief of Heartburn in Adolescents

Completed
2
63
US, Europe, RoW
Dexlansoprazole, Dexilant, Placebo
Takeda
Gastroesophageal Reflux Disease, Erosive Esophagitis
11/14
11/14
NCT01479231: Predictors of Proton Pump Inhibitor (PPI) Response in Eosinophilic Esophagitis

Withdrawn
1/2
0
US
dexlansoprazole, Dexilant
Mayo Clinic
Gastroesophageal Reflux Disease, Eosinophilic Esophagitis, Dysphagia
03/12
03/12

Download Options